Short description: Monoclonal antibody
Edobacomab, codenamed E5, is a mouse monoclonal antibody that was investigated as a possible treatment for sepsis caused by Gram-negative bacterial infections.
Further reading
- "A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group". JAMA 266 (8): 1097–102. August 1991. doi:10.1001/jama.266.8.1097. PMID 1865542.
- "A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group". Critical Care Medicine 23 (6): 994–1006. June 1995. doi:10.1097/00003246-199506000-00003. PMID 7774238.
- "E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators". JAMA 283 (13): 1723–30. April 2000. doi:10.1001/jama.283.13.1723. PMID 10755499.
|
|---|
| Fungal ("-fung-") | |
|---|
| Viral ("-v(i)[r]-") | |
|---|
| Bacterial ("-ba(c)-") | | Human ("-bacu-") | |
|---|
| Mouse ("-baco-") | |
|---|
| Chimeric ("-baxi-") | |
|---|
| Humanized ("-bazu-") | |
|---|
|
|---|
| Toxin ("-tox(a)-") | | Human ("-toxu-") | |
|---|
| Chimeric ("-toxaxi-") | |
|---|
| Humanized ("-toxazu-") | |
|---|
|
|---|
|
 | Original source: https://en.wikipedia.org/wiki/Edobacomab. Read more |